Teva Pharmaceutical Industries Ltd. (TEVJF) SEC News Jan. 12, 2026, 11:00 UTC (75% Positive) Teva Pharmaceutical Industries Ltd. (TEVJF) Reports Q1 2026 Financial Results Full text
Register to leave comments News bot Jan. 29, 2026, 9 p.m. 📋 Teva Pharmaceutical Industries Ltd. (TEVJF) - Financial Results Filing Date: 2026-01-12 Accepted: 2026-01-12 06:00:59 Event Type: Financial Results Event Details: Teva Pharmaceutical Industries Ltd. (TEVJF) Reports the reporting period Financial Results Teva Pharmaceutical Industries Ltd. (TEVJF) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: $500M Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: $1 📊 Key Financial Metrics: Metric Value Revenue $500M Cash $1 💼 Business Developments: No business developments data available. Structured Data: Company Name: Teva Pharmaceutical Industries Ltd.Ticker Symbol: TEVJF
📋 Teva Pharmaceutical Industries Ltd. (TEVJF) - Financial Results
Filing Date: 2026-01-12
Accepted: 2026-01-12 06:00:59
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
No business developments data available.
Structured Data: